Adverse Drug Reaction Classification System

ADR Ontology
ADR Term Demyelinating disorders
ADR ID BADD_A01193
ADR Hierarchy
17      Nervous system disorders
17.16      Demyelinating disorders
Description Diseases characterized by loss or dysfunction of myelin in the central or peripheral nervous system. | The first region-restricted episode of CNS inflammatory demyelination in a patient. It is usually characterized by an acute monosymptomatic presentation of the optic nerves, brainstem, or spinal cord. It may not reoccur (isolated), or it may progress to MULTIPLE SCLEROSIS. [MeSH]
MedDRA Code 10012303
MeSH ID D003711
ADR Severity Grade (FAERS)
ADR Severity Grade (CTCAE) Not Available
Synonym
Demyelinating Diseases | Demyelinating Disease | Demyelinating Disorders | Demyelinating Disorder | Demyelination | Demyelinations | Clinically Isolated Syndrome, CNS Demyelinating | Clinically Isolated CNS Demyelinating Syndrome
Drugs Leading to the ADR
Drug IDDrug NameADR Frequency (FAERS)ADR Severity Grade (FAERS)
BADD_D02236Tofacitinib0.001206%
BADD_D02244Tolterodine0.000339%
BADD_D02246Tolvaptan0.000611%
BADD_D02247Topiramate0.000302%
BADD_D02329Valproic acid0.000998%
BADD_D02332Vancomycin--
BADD_D02337Varenicline0.000487%
BADD_D02338Varenicline tartrate--
BADD_D02342Vedolizumab--
BADD_D02346Venlafaxine0.000048%
BADD_D02355Vigabatrin0.000187%
BADD_D02375Water--
BADD_D02393Zolmitriptan--
BADD_D02407Upadacitinib0.000482%
BADD_D02412Octreotide0.000186%
BADD_D02445Solifenacin0.000260%
BADD_D02464Fingolimod0.262861%
BADD_D02473Sodium chloride0.002534%
BADD_D02511Siponimod0.020157%
BADD_D02550Diroximel fumarate0.027632%
BADD_D02580Ozanimod0.058349%
BADD_D02584Ponesimod0.000482%
The 5th Page    First    Pre   5    Total 5 Pages